ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

MBRX Moleculin Biotech Inc

5.01
0.38 (8.21%)
30 4월(4) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Moleculin Biotech Inc MBRX 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.38 8.21% 5.01 09:00:00
개장가 저가 고가 종가 전일 종가
4.80 4.80 5.25 5.01 4.63
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
18/04/202421:30PRNUSEuropean Medicines Agency (EMA) Grants Orphan Drug..
10/04/202421:30PRNUSMoleculin Announces Presentation of Positive Data..
28/03/202423:45PRNUSMoleculin to Present at the MedInvest Biotech & Pharma..
27/03/202422:25PRNUSMoleculin to Participate in the Virtual Investor Lunch..
27/03/202422:05PRNUSMoleculin Announces U.S. Patent Issue Notification for..
25/03/202420:30PRNUSMoleculin Announces Positive Interim Data in Annamycin..
23/03/202405:05PRNUSMoleculin Reports Full Year 2023 Financial Results
20/03/202420:30PRNUSMoleculin to Report Full Year 2023 Financial Results on..
20/03/202420:15IHMARKETNEWSJPMorgan boosts dividends, Chipotle unveils 50:1 stock..
20/03/202405:30PRNUSMoleculin Announces Reverse Stock Split
12/03/202422:05PRNUSMoleculin to Present at the 36th Annual ROTH Conference
29/02/202422:30EDGAR2Form 8-K - Current report
22/02/202423:30EDGAR2Form 8-K - Current report
17/02/202407:19EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
15/02/202423:15EDGAR2Form 8-K - Current report
15/02/202406:36EDGAR2Form 8-K - Current report
15/02/202406:33EDGAR2Form 8-K - Current report
13/02/202414:15EDGAR2Form EFFECT - Notice of Effectiveness
03/02/202407:05EDGAR2Form S-1 - General form for registration of securities under..
24/01/202422:50EDGAR2Form 8-K - Current report
24/01/202422:50PRNUSMoleculin Announces 2023 Year-End Annamycin Clinical Trials..
17/01/202407:00EDGAR2Form DEF 14A - Other definitive proxy statements
06/01/202407:15EDGAR2Form PRE 14A - Other preliminary proxy statements
06/01/202407:14EDGAR2Form 8-K - Current report
27/12/202321:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/12/202307:00EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
22/12/202307:17EDGAR2Form 8-K - Current report
21/12/202311:16PRNUSMoleculin Announces Pricing of $4.5 Million Registered..
18/12/202322:55EDGAR2Form 8-K - Current report
11/12/202322:55EDGAR2Form 8-K - Current report
11/12/202322:50EDGAR2Form 8-K - Current report
11/12/202322:50PRNUSMoleculin Presents Positive Interim Data from Phase 1B/2..
20/11/202323:15EDGAR2Form 8-K - Current report
13/11/202322:30EDGAR2Form 8-K - Current report
13/11/202322:05EDGAR2Form 8-K - Current report
13/11/202322:05PRNUSMoleculin Announces Positive Interim Data in Annamycin..
13/11/202322:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202322:00EDGAR2Form 8-K - Current report
13/11/202322:00PRNUSMoleculin Reports Third Quarter 2023 Financial Results
07/11/202322:45EDGAR2Form 8-K - Current report
07/11/202322:45PRNUSMoleculin to Report Third Quarter Financial Results on..
06/11/202322:35EDGAR2Form 8-K - Current report
06/11/202322:35PRNUSMoleculin Presents Positive Preliminary Efficacy Findings..
04/11/202305:30EDGAR2Form 8-K - Current report
17/10/202322:00EDGAR2Form 8-K - Current report
11/10/202322:05PRNUSMoleculin to Participate in the Virtual Investor Ask the CEO..
07/10/202306:15EDGAR2Form 8-K - Current report
02/10/202321:40EDGAR2Form 8-K - Current report
02/10/202321:40PRNUSMoleculin Doses First Subjects in Phase 2 Portion of..
21/09/202321:50EDGAR2Form 8-K - Current report

최근 히스토리

Delayed Upgrade Clock